Apellis Pharmaceuticals, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy

54

APLS
Apellis Pharmaceuticals, Inc.

Last Price:

$24.70

Seasonality Move:

12.69%

Buy

87

KYMR
Kymera Therapeutics, Inc.

Last Price:

$89.98

Seasonality Move:

7.7%

Buy

54

Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.78. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

87

Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

The Apellis Pharmaceuticals, Inc. share price today is $23.78

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

The Kymera Therapeutics, Inc. share price today is $86.88

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.17	Buy
Relative Strength Index (14 RSI):	62.16	Buy
Chaikin Money Flow:	-415477	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(19.31 - 22.05)	Buy
Bollinger Bands (100):	(20.59 - 26.87)	Buy

KYMR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4.97	Buy
Relative Strength Index (14 RSI):	72.81	Buy
Chaikin Money Flow:	-897315	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(58.72 - 73.96)	Buy
Bollinger Bands (100):	(43.27 - 64.19)	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	22.23	Buy
20-day SMA:	20.93	Buy
50-day SMA:	22.98	Buy
200-day SMA:	21.94	Buy
8-day EMA:	22.53	Buy
20-day EMA:	21.85	Buy
50-day EMA:	22.44	Buy
200-day EMA:	24.22	Sell

KYMR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	72.38	Buy
20-day SMA:	67.89	Buy
50-day SMA:	62.54	Buy
200-day SMA:	44.51	Buy
8-day EMA:	75.59	Buy
20-day EMA:	69.41	Buy
50-day EMA:	62.91	Buy
200-day EMA:	49.79	Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

	Nov 25	Nov 26	Nov 28	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9
	Nov				Dec
	25	26	28	01	02	03	04	05	08	09
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

	Nov 25	Nov 26	Nov 28	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9
	Nov				Dec
	25	26	28	01	02	03	04	05	08	09
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):